Cargando…

Abstract No.: ABS0288: Comparison of the effect of two balanced crystalloid intraoperative (intravenous) solutions (PlasmalyteTM versus Sterofundin TM) on lactate levels during major cancer surgeries.

BACKGROUND &AIMS: Use of balanced fluids as intra-operative fluids substantially decrease the incidence of lactic acidosis; especially after major cancer surgeries. Aim of present study was to compare the effects of two acetate based balanced solutions, PlasmalyteTM and SterofundinTM on lactate,...

Descripción completa

Detalles Bibliográficos
Autor principal: Gupta, Deepti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116789/
http://dx.doi.org/10.4103/0019-5049.340678
_version_ 1784710185399353344
author Gupta, Deepti
author_facet Gupta, Deepti
author_sort Gupta, Deepti
collection PubMed
description BACKGROUND &AIMS: Use of balanced fluids as intra-operative fluids substantially decrease the incidence of lactic acidosis; especially after major cancer surgeries. Aim of present study was to compare the effects of two acetate based balanced solutions, PlasmalyteTM and SterofundinTM on lactate, pH, electrolytes and haemodynamics after major onco-surgery. METHODS: In this prospective randomised parallel group study, 60 patients undergoing major onco surgeries were randomised in one o fthe two groups to receive either PlasmalyteTM (PL) (30 patients) or SterofundinTM (SF) (30 patients) as an intra-operative fluid. Arterial Blood Gas analysis (ABG) was sampled before surgery (Baseline) and at the time of haemostasis (Post surgery). Heart rate and mean blood pressure were noted every 30 minutes. Blood loss during surgery was replaced with either colloid or blood. Descriptive statistical analyses, including mean and standard deviation for continuous variables, and count and percentage for categorical variables was performed. Student t-test was used to compare continuous variables and Fisher’s exact test was used for categorical variables. p <0.05 was considered to indicate statistical significance. Analysis was performed using SPSS Version 23.0 software. RESULTS: The patient’s age was found to be comparable in both the groups (p=0.19). There was not any statistically significant difference seen in lactate (p=0.085) or pH (p=0.89) values between the two groups. Electrolyte levels were well maintained within normal limits in both PL and SF groups except calcium which was significantly higher in SF group post surgery(p<0.001). Difference in heart rate and mean blood pressure was found to be insignificant at all time points. Blood loss during the surgery was also similar in both the groups (p=0.937). CONCLUSION: Both PL and SF balanced crystalloid solutions can be safely recommended as an intraoperative fluid in major oncological surgeries. Both the fluids effectively maintain the pH and significantly decrease the incidence of lactic acidosis during cancer surgeries. Calcium levels are better maintained with the infusion of Sterofundin solution.
format Online
Article
Text
id pubmed-9116789
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91167892022-05-19 Abstract No.: ABS0288: Comparison of the effect of two balanced crystalloid intraoperative (intravenous) solutions (PlasmalyteTM versus Sterofundin TM) on lactate levels during major cancer surgeries. Gupta, Deepti Indian J Anaesth Kops Award Abstracts: Clinical Pharmacology BACKGROUND &AIMS: Use of balanced fluids as intra-operative fluids substantially decrease the incidence of lactic acidosis; especially after major cancer surgeries. Aim of present study was to compare the effects of two acetate based balanced solutions, PlasmalyteTM and SterofundinTM on lactate, pH, electrolytes and haemodynamics after major onco-surgery. METHODS: In this prospective randomised parallel group study, 60 patients undergoing major onco surgeries were randomised in one o fthe two groups to receive either PlasmalyteTM (PL) (30 patients) or SterofundinTM (SF) (30 patients) as an intra-operative fluid. Arterial Blood Gas analysis (ABG) was sampled before surgery (Baseline) and at the time of haemostasis (Post surgery). Heart rate and mean blood pressure were noted every 30 minutes. Blood loss during surgery was replaced with either colloid or blood. Descriptive statistical analyses, including mean and standard deviation for continuous variables, and count and percentage for categorical variables was performed. Student t-test was used to compare continuous variables and Fisher’s exact test was used for categorical variables. p <0.05 was considered to indicate statistical significance. Analysis was performed using SPSS Version 23.0 software. RESULTS: The patient’s age was found to be comparable in both the groups (p=0.19). There was not any statistically significant difference seen in lactate (p=0.085) or pH (p=0.89) values between the two groups. Electrolyte levels were well maintained within normal limits in both PL and SF groups except calcium which was significantly higher in SF group post surgery(p<0.001). Difference in heart rate and mean blood pressure was found to be insignificant at all time points. Blood loss during the surgery was also similar in both the groups (p=0.937). CONCLUSION: Both PL and SF balanced crystalloid solutions can be safely recommended as an intraoperative fluid in major oncological surgeries. Both the fluids effectively maintain the pH and significantly decrease the incidence of lactic acidosis during cancer surgeries. Calcium levels are better maintained with the infusion of Sterofundin solution. Wolters Kluwer - Medknow 2022-03 /pmc/articles/PMC9116789/ http://dx.doi.org/10.4103/0019-5049.340678 Text en Copyright: © 2022 Indian Journal of Anaesthesia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Kops Award Abstracts: Clinical Pharmacology
Gupta, Deepti
Abstract No.: ABS0288: Comparison of the effect of two balanced crystalloid intraoperative (intravenous) solutions (PlasmalyteTM versus Sterofundin TM) on lactate levels during major cancer surgeries.
title Abstract No.: ABS0288: Comparison of the effect of two balanced crystalloid intraoperative (intravenous) solutions (PlasmalyteTM versus Sterofundin TM) on lactate levels during major cancer surgeries.
title_full Abstract No.: ABS0288: Comparison of the effect of two balanced crystalloid intraoperative (intravenous) solutions (PlasmalyteTM versus Sterofundin TM) on lactate levels during major cancer surgeries.
title_fullStr Abstract No.: ABS0288: Comparison of the effect of two balanced crystalloid intraoperative (intravenous) solutions (PlasmalyteTM versus Sterofundin TM) on lactate levels during major cancer surgeries.
title_full_unstemmed Abstract No.: ABS0288: Comparison of the effect of two balanced crystalloid intraoperative (intravenous) solutions (PlasmalyteTM versus Sterofundin TM) on lactate levels during major cancer surgeries.
title_short Abstract No.: ABS0288: Comparison of the effect of two balanced crystalloid intraoperative (intravenous) solutions (PlasmalyteTM versus Sterofundin TM) on lactate levels during major cancer surgeries.
title_sort abstract no.: abs0288: comparison of the effect of two balanced crystalloid intraoperative (intravenous) solutions (plasmalytetm versus sterofundin tm) on lactate levels during major cancer surgeries.
topic Kops Award Abstracts: Clinical Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116789/
http://dx.doi.org/10.4103/0019-5049.340678
work_keys_str_mv AT guptadeepti abstractnoabs0288comparisonoftheeffectoftwobalancedcrystalloidintraoperativeintravenoussolutionsplasmalytetmversussterofundintmonlactatelevelsduringmajorcancersurgeries